FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621587958> ?p ?o ?g. }

• W2621587958 endingPage "702" @default.
• W2621587958 startingPage "696" @default.
• W2621587958 abstract "Objective To determine optimal percent reduction and raw score cutoffs on the parent- and child-report Screen for Child Anxiety Related Emotional Disorders (SCARED) for predicting treatment response and remission among youth with anxiety disorders. Method Data were obtained from youth (N = 438; 7–17 years old) who completed treatment in the Child/Adolescent Anxiety Multimodal treatment Study, a multisite, randomized clinical trial that examined the relative efficacy of medication (sertraline), cognitive-behavioral therapy (Coping Cat), their combination, and pill placebo for the treatment of separation anxiety disorder, generalized anxiety disorder, and social phobia. The parent- and youth-report SCARED were administered at pre- and posttreatment. Quality receiver operating characteristic methods evaluated the performance of various SCARED percent reduction and absolute cutoff scores in predicting treatment response and remission, as defined by posttreatment ratings on the Clinical Global Impression scales and the Anxiety Disorders Interview Schedule. Results Reductions of 55% on the SCARED-Parent and 50% on the SCARED-Youth optimally predicted treatment response. Posttreatment absolute raw scores of 10 (SCARED-Parent) and 12 (SCARED-Youth) optimally predicted remission in the total sample, although separate SCARED-Parent cutoffs for children (12–13) and adolescents (9) showed greatest quality of efficiency. Each cutoff significantly predicted response and remission at 6-month follow-up. Conclusion Results serve as guidelines for operationalizing treatment response and remission on the SCARED, which could help clinicians systematically monitor treatment outcomes of youth with anxiety disorders in a cost- and time-efficient manner. Clinical trial registration information—Child and Adolescent Anxiety Disorders (CAMS); http://clinicaltrials.gov/; NCT00052078. To determine optimal percent reduction and raw score cutoffs on the parent- and child-report Screen for Child Anxiety Related Emotional Disorders (SCARED) for predicting treatment response and remission among youth with anxiety disorders. Data were obtained from youth (N = 438; 7–17 years old) who completed treatment in the Child/Adolescent Anxiety Multimodal treatment Study, a multisite, randomized clinical trial that examined the relative efficacy of medication (sertraline), cognitive-behavioral therapy (Coping Cat), their combination, and pill placebo for the treatment of separation anxiety disorder, generalized anxiety disorder, and social phobia. The parent- and youth-report SCARED were administered at pre- and posttreatment. Quality receiver operating characteristic methods evaluated the performance of various SCARED percent reduction and absolute cutoff scores in predicting treatment response and remission, as defined by posttreatment ratings on the Clinical Global Impression scales and the Anxiety Disorders Interview Schedule. Reductions of 55% on the SCARED-Parent and 50% on the SCARED-Youth optimally predicted treatment response. Posttreatment absolute raw scores of 10 (SCARED-Parent) and 12 (SCARED-Youth) optimally predicted remission in the total sample, although separate SCARED-Parent cutoffs for children (12–13) and adolescents (9) showed greatest quality of efficiency. Each cutoff significantly predicted response and remission at 6-month follow-up. Results serve as guidelines for operationalizing treatment response and remission on the SCARED, which could help clinicians systematically monitor treatment outcomes of youth with anxiety disorders in a cost- and time-efficient manner." @default.
• W2621587958 created "2017-06-15" @default.
• W2621587958 creator A5000123060 @default.
• W2621587958 creator A5000891917 @default.
• W2621587958 creator A5009788220 @default.
• W2621587958 creator A5014163066 @default.
• W2621587958 creator A5021797768 @default.
• W2621587958 creator A5032710781 @default.
• W2621587958 creator A5035836400 @default.
• W2621587958 creator A5041320761 @default.
• W2621587958 creator A5060868612 @default.
• W2621587958 creator A5061265687 @default.
• W2621587958 creator A5077663448 @default.
• W2621587958 date "2017-08-01" @default.
• W2621587958 modified "2023-10-16" @default.
• W2621587958 title "Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED)" @default.
• W2621587958 cites W1581892737 @default.
• W2621587958 cites W1966681606 @default.
• W2621587958 cites W1971212202 @default.
• W2621587958 cites W1976348233 @default.
• W2621587958 cites W1990748933 @default.
• W2621587958 cites W1991448989 @default.
• W2621587958 cites W2009496135 @default.
• W2621587958 cites W2013307743 @default.
• W2621587958 cites W2021623061 @default.
• W2621587958 cites W2032404423 @default.
• W2621587958 cites W2037789405 @default.
• W2621587958 cites W2040768505 @default.
• W2621587958 cites W2044740696 @default.
• W2621587958 cites W2059569234 @default.
• W2621587958 cites W2061314614 @default.
• W2621587958 cites W2067839639 @default.
• W2621587958 cites W2082999856 @default.
• W2621587958 cites W2093368776 @default.
• W2621587958 cites W2103828219 @default.
• W2621587958 cites W2121595510 @default.
• W2621587958 cites W2126948325 @default.
• W2621587958 cites W2131873172 @default.
• W2621587958 cites W2134000132 @default.
• W2621587958 cites W2149402043 @default.
• W2621587958 cites W2150098143 @default.
• W2621587958 cites W2152575748 @default.
• W2621587958 cites W2153696682 @default.
• W2621587958 cites W2154364243 @default.
• W2621587958 cites W2157318188 @default.
• W2621587958 cites W2534305935 @default.
• W2621587958 cites W3122856402 @default.
• W2621587958 cites W4236592671 @default.
• W2621587958 doi "https://doi.org/10.1016/j.jaac.2017.05.018" @default.
• W2621587958 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5546231" @default.
• W2621587958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28735699" @default.
• W2621587958 hasPublicationYear "2017" @default.
• W2621587958 type Work @default.
• W2621587958 sameAs 2621587958 @default.
• W2621587958 citedByCount "30" @default.
• W2621587958 countsByYear W26215879582017 @default.
• W2621587958 countsByYear W26215879582018 @default.
• W2621587958 countsByYear W26215879582019 @default.
• W2621587958 countsByYear W26215879582020 @default.
• W2621587958 countsByYear W26215879582021 @default.
• W2621587958 countsByYear W26215879582022 @default.
• W2621587958 countsByYear W26215879582023 @default.
• W2621587958 crossrefType "journal-article" @default.
• W2621587958 hasAuthorship W2621587958A5000123060 @default.
• W2621587958 hasAuthorship W2621587958A5000891917 @default.
• W2621587958 hasAuthorship W2621587958A5009788220 @default.
• W2621587958 hasAuthorship W2621587958A5014163066 @default.
• W2621587958 hasAuthorship W2621587958A5021797768 @default.
• W2621587958 hasAuthorship W2621587958A5032710781 @default.
• W2621587958 hasAuthorship W2621587958A5035836400 @default.
• W2621587958 hasAuthorship W2621587958A5041320761 @default.
• W2621587958 hasAuthorship W2621587958A5060868612 @default.
• W2621587958 hasAuthorship W2621587958A5061265687 @default.
• W2621587958 hasAuthorship W2621587958A5077663448 @default.
• W2621587958 hasBestOaLocation W26215879582 @default.
• W2621587958 hasConcept C118552586 @default.
• W2621587958 hasConcept C126322002 @default.
• W2621587958 hasConcept C15744967 @default.
• W2621587958 hasConcept C2777669559 @default.
• W2621587958 hasConcept C2779177272 @default.
• W2621587958 hasConcept C535046627 @default.
• W2621587958 hasConcept C558461103 @default.
• W2621587958 hasConcept C70410870 @default.
• W2621587958 hasConcept C71924100 @default.
• W2621587958 hasConceptScore W2621587958C118552586 @default.
• W2621587958 hasConceptScore W2621587958C126322002 @default.
• W2621587958 hasConceptScore W2621587958C15744967 @default.
• W2621587958 hasConceptScore W2621587958C2777669559 @default.
• W2621587958 hasConceptScore W2621587958C2779177272 @default.
• W2621587958 hasConceptScore W2621587958C535046627 @default.
• W2621587958 hasConceptScore W2621587958C558461103 @default.
• W2621587958 hasConceptScore W2621587958C70410870 @default.
• W2621587958 hasConceptScore W2621587958C71924100 @default.
• W2621587958 hasIssue "8" @default.
• W2621587958 hasLocation W26215879581 @default.
• W2621587958 hasLocation W26215879582 @default.
• W2621587958 hasLocation W26215879583 @default.
• W2621587958 hasLocation W26215879584 @default.

• next